# US 2024/0093167 A1 · Esterase Mutant and Use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0093167 A1
- Document ID: US20240093167A1
- Status: Published application
- Kind: A1
- Application number: 18/262,480
- Filed: 2021-03-02
- Published: 2024-03-21
- Earliest claimed: 2021-01-27
- Assignees: Asymchem Life Science (Tianjin) Co., Ltd.
- Applicants: Asymchem Life Science (Tianjin) Co., Ltd.
- Inventors: Hao Hong; James Gage; Yi Xiao; Na Zhang; Xuecheng Jiao; Yiming Yang; Xiang Wang; Junqi Zhao
- Web page: https://patentgrep.com/patent/US20240093167A1

## CPC

- C12N 9/18: Carboxylic ester hydrolases {(3.1.1)}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/81: for yeasts
- C12P 7/40: containing a carboxyl group {including Peroxycarboxylic acids}
- C12P 41/005: {by esterification of carboxylic acid groups in the enantiomers or the inverse reaction}
- C12Y 301/01: Carboxylic ester hydrolases (3.1.1)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

Provided are an esterase mutant and use thereof. The amino acid sequence of the esterase mutant has a sequence as shown in SEQ ID NO: 1, and sites at which amino acid mutations occur include an N51G site.

## Claims

### Claim 1

An esterase mutant having an amino acid sequence obtained by the mutation of the amino acid sequence shown in SEQ ID NO: 1, and the mutation comprises a mutation site N51G.

### Claim 2 (depends on 1)

The esterase mutant according to claim 1, wherein the mutation comprises any one of the following mutation site combinations: N51G+T117M+S140G, N51G+T117M+S140N, N51G+T117M+S140C, N51G+T117M+S140T, N51G+T117M+S140A, N51G+T117M+A142V, N51G+T117M+A142P, N51G+T117M+A142S, N51G+T117M+A142L, N51G+T117M+D217Q, N51G+T117M+D217A, N51G+T117M+D217S, N51G+T117M+D217G, N51G+T117M+L231I, N51G+T117M+S140C+M52F, N51G+T117M+S140C+M52L, N51G+T117M+S140C+M52N, N51G+T117M+S140C+M52Y, N51G+T117M+S140C+M52G, N51G+T117M+S140C+M52W, N51G+T117M+S140C+I195F, N51G+T117M+S140C+I195L, N51G+T117M+S140C+I195T, N51G+T117M+S140C+I195V, N51G+T117M+S140C+D217S, N51G+T117M+S140C+L231I, N51G+T117M+S140C+V267I, N51G+T117M+S140C+I268V, N51G+T117M+S140C+S295F, N51G+T117M+S140C+S295M, N51G+T117M+S140C+S295N, N51G+T117M+S140C+S295G, or N51G+T117M+S140C+S295D.

### Claim 3 (depends on 1)

A DNA molecule encoding the esterase mutant according to claim 1.

### Claim 4 (depends on 3)

A recombinant plasmid containing the DNA molecule according to claim 3.

### Claim 5 (depends on 4)

The recombinant plasmid according to claim 4, wherein the recombinant plasmid is pET-22b(+), pET-22b(+), pET-3a(+), pET-3d(+), pET-11a(+), pET-12a(+), pET-14b, pET-15b(+), pET-16b(+), pET-17b(+), pET-19b(+), pET-20b(+), pET-21a(+), pET-23a(+), pET-23b(+), pET-24a(+), pET-25b(+), pET-26b(+), pET-27b(+), pET-28a(+), pET-29a(+), pET-30a(+), pET-31b(+), pET-32a(+), pET-35b(+), pET-38b(+), pET-39b(+), pET-40b(+), pET-41a(+), pET-41b(+), pET-42a(+), pET-43a(+), pET-43b(+), pET-44a(+), pET-49b(+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, pGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, pKK232-8, pUC-18, or pUC-19.

### Claim 6 (depends on 4)

A host cell containing the recombinant plasmid according to claim 4.

### Claim 7 (depends on 6)

The host cell according to claim 6, wherein the host cell comprises a prokaryotic cell or a eukaryotic cell.

### Claim 8 (depends on 7)

The host cell according to claim 7, wherein the prokaryotic cell is Escherichia coliBL21 cell or Escherichia coli DH5α competent cell, and the eukaryotic cell is yeast.

### Claim 9 (depends on 1)

A method for producing chiral acids, comprising a step of catalyzing a reaction of ester compound by an esterase, wherein the esterase is the esterase mutant according to claim 1.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the ester compound is
and reaction product is
wherein R1 represents —CH3, —CH2CH3, —CH2CH2CH3, or —CHCH3CH3; R2, R3, R4, and R5 each independently represent —H, —F, —Cl, —Br, —CH3, or —CH2CH3.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the ester compound is

### Claim 12 (depends on 10)

The method according to claim 10, wherein a pH of the reaction catalyzed by an esterase mutant is 8.5 to 9.0, and a reaction temperature is 30° C. to 35° C.
